Topiramate Capsule, Extended Release
Product Images NDC 10370-366

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10370-366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical_structure.jpg (Topiramate 1)

Chemical structure of Topiramate, depicting its molecular framework including multiple oxygen atoms, methyl groups, and a sulfonamide functional group.*

FDA Label Image

Figure 1.jpg (Topiramate 2)

A cumulative rate chart depicting time to first seizure for Topiramate at 50 mg/day and 400 mg/day dosages. The x-axis shows time in days up to 500 days, and the y-axis represents cumulative rates to first seizure. Two lines compare the seizure rates for the two dosage groups, with 50 mg/day showing higher cumulative rates than 400 mg/day, and a statistical p-value of 0.0002 is noted.*

FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 1 And 2 For Adults And Adolescents) (Topiramate 3)

A bar chart depicting change from baseline to double-blind phase in average monthly migraine period rate (+SE) comparing placebo with topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Two studies are represented by separate bars for each group, showing a dose-dependent decrease in migraine rate with topiramate compared to placebo, with statistical significance indicated for 100 mg/day and 200 mg/day doses.*

FDA Label Image

25_mg_-_30s_-par_health_chennai.jpg (Topiramate 4)

Label for Topiramate Extended-Release Capsules 25 mg by Par Health USA, LLC. The label indicates a prescription drug with 30 capsules per bottle. Capsules are orange opaque. Storage instructions specify 20° to 25°C. The label includes warnings to swallow whole and not to crush or chew.*

FDA Label Image

50_mg_-_30s_-par_health_chennai.jpg (Topiramate 5)

Label for Topiramate Extended-Release Capsules 50 mg by Par Health USA, LLC. The white label includes dosage instructions, caution to swallow capsules whole, and storage information. It specifies the 50 mg strength with flesh opaque capsule appearance, quantity of 30 capsules, and is marked Rx only.*

FDA Label Image

100_mg_-_30s_-par_health_chennai.jpg (Topiramate 6)

Label for Topiramate Extended-Release Capsules 100 mg by Par Health USA, LLC. The label states this is a prescription drug with 30 capsules per bottle. Directions advise swallowing the capsule whole without opening or crushing. Storage instructions specify 20° to 25°C and protection from moisture and light. The label includes usage and dispensing guidance, a barcode, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.